In Vitro and In Vivo Improvement of Islet Survival Following Treatment with Nerve Growth Factor
- 27 February 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 81 (4), 519-524
- https://doi.org/10.1097/01.tp.0000200320.16723.b3
Abstract
Background. Nerve growth factor (NGF) has been reported to play an important regulatory role in pancreatic beta-cell function. However, the usefulness of NGF in a transplantation setting is unknown. Methods. A marginal number of islet cells (260 islet equivalents/recipient) cultured for 24 hr with NGF (500 ng/ml) was syngeneically transplanted under the kidney capsule of streptozotocin-induced diabetic Balb/c mice. Fluorescence microscopy was used to evaluate islet viability. Islet function was evaluated in vitro and in vivo by static assay and glucose tolerance test, respectively. Results. In vitro, improved viability and survival were found in murine islets cultured in serum-free medium for 96 hr with 500 ng/ml NGF (PP<0.05), and 20 mmol/L glucose conditions. In vivo, 67% of recipients with a submarginal number of islets cultured in NGF attained normoglycemia for more than 120 days, whereas transplanted islets without NGF treatment survived a maximum of 13 days in control mice. At posttransplant day 4, recipients of NGF-cultured islets showed significant improvement of glucose tolerance. On immunohistochemistry, the kidney capsules containing NGF-cultured islets displayed higher insulin content, and more dilated neoplastic microvessels than control renal capsules. The number of apoptotic cells using TUNEL staining decreased by nearly 50% in NGF-cultured islet grafts in comparison to control islet grafts. Conclusions. The above data suggest potential advantages of NGF for islet survival following transplantation. This neurotrophic approach may prove beneficial in human islet transplantation.This publication has 27 references indexed in Scilit:
- Successful Islet TransplantationDiabetes, 2002
- Islet cell transplantationThe Lancet, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenThe New England Journal of Medicine, 2000
- Neuron-like phenotypic changes in pancreatic β-cells induced by NGF, FGF, and dbcAMPEndocrine, 1996
- Glucose, Other Secretagogues, and Nerve Growth Factor Stimulate Mitogen-activated Protein Kinase in the Insulin-secreting β-Cell Line, INS-1Online Journal of Public Health Informatics, 1995
- A SELECTIVE DECREASE IN THE BETA CELL MASS OF HUMAN ISLETS TRANSPLANTED INTO DIABETIC NUDE MICETransplantation, 1995
- Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Nerve growth factor revisitedTrends in Biochemical Sciences, 1993
- Automated Islet Isolation From Human PancreasDiabetes, 1989
- The Nerve Growth Factor 35 Years LaterScience, 1987